文献速递复苏、休克与脓毒症心脑血管急症

伊伐布雷定对猪心脏骤停模型复苏后心肌功能障碍的有益作用

Beneficial Effects of Ivabradine on Post-Resuscitation Myocardial Dysfunction in a Porcine Model of Cardiac Arrest.
PubMed 文献 · Shock · 2020-01-01
一句话结论猪心脏骤停模型中,复苏后5分钟给予伊伐布雷定可减慢心率、改善复苏后心肌功能障碍与心肌损伤,并降低神经功能缺损评分。

该研究在麻醉家猪中诱导心室颤动8分钟、心肺复苏6分钟后电除颤,复苏后随机分为伊伐布雷定组与安慰剂组(每组5只)。伊伐布雷定于自主循环恢复后5分钟给药,随后以0.5 mg/kg持续静脉输注480分钟。结果显示伊伐布雷定组复苏后1小时起心率显著降低,二尖瓣E/A与E/e'比值及左心室射血分数显著优于安慰剂组,NT-proBNP、cTnI及心肌活检评分显著降低,复苏后24小时神经功能缺损评分更低。作者结论认为伊伐布雷定改善了该猪模型的复苏后心肌功能障碍、心肌损伤及复苏后脑功能,并减慢心率。

要点

  • 猪心室颤动模型复苏后5分钟给予伊伐布雷定,复苏后1小时起心率显著低于安慰剂组(P<0.05)。
  • 伊伐布雷定组复苏后二尖瓣E/A、E/e'比值及左心室射血分数显著优于安慰剂组(P<0.05)。
  • 伊伐布雷定组血清NT-proBNP、cTnI及心肌活检评分显著低于安慰剂组(P<0.05)。
  • 伊伐布雷定组复苏后24小时神经功能缺损评分显著低于安慰剂组(P<0.05)。
  • 该研究为猪模型、每组5只,结论不能直接外推为临床推荐。

适用人群与场景

  • 麻醉家猪心室颤动模型,心室颤动8分钟未处理、心肺复苏6分钟后电除颤,自主循环恢复后进入研究。

处置流程与药物剂量

  • 伊伐布雷定与生理盐水以相同体积于自主循环恢复后5分钟给药,随后以0.5 mg/kg持续静脉输注480分钟(原文未分别写明负荷量与输注速率的单位细节)。

研究设计与关键结果

  • 研究类型为猪心脏骤停模型实验,伊伐布雷定组与安慰剂组各5只。
  • 伊伐布雷定组自复苏后1小时起心率显著降低(所有P<0.05)。
  • 复苏后二尖瓣E/A、E/e'比值及左心室射血分数伊伐布雷定组显著优于安慰剂组(P<0.05)。
  • 血清NT-proBNP、cTnI及心肌活检评分伊伐布雷定组显著低于安慰剂组(P<0.05)。
  • 复苏后24小时神经功能缺损评分伊伐布雷定组低于安慰剂组(P<0.05)。

证据类型、等级与局限

  • 证据类型:动物实验(猪心脏骤停模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在该猪模型中伊伐布雷定改善了复苏后心肌功能障碍、心肌损伤及复苏后脑功能,并减慢心率。
  • 该结果为动物模型、每组5只,原文未据此给出临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Ivabradine selectively inhibits the If current, reducing the heart rate and protecting against myocardial ischemia/reperfusion injury. We investigated the effects of ivabradine on post-resuscitation myocardial function in a porcine model of cardiopulmonary resuscitation.

METHODS AND RESULTS: Ventricular fibrillation was induced and untreated for 8 min while defibrillation was attempted after 6 min of cardiopulmonary resuscitation in anesthetized domestic swine. Then the animals were randomized into ivabradine and placebo groups (n = 5 each). Ivabradine and saline were administered at the same volume 5 min after Return of Spontaneous Circulation, followed by continuous intravenous infusion at 0.5 mg/kg for 480 min. Hemodynamic parameters were continuously recorded. Myocardial function was assessed by echocardiography at baseline and at 60, 120, 240, 480 min and 24 h after resuscitation. The serum levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) and cardiac troponin I (cTnI) were measured by commercial enzyme-linked immunosorbent assay kits. Animals were killed 24 h after resuscitation, and all myocardial tissue was removed for histopathological analysis. The heart rate was significantly reduced from 1 h after resuscitation in the ivabradine group (all P < 0.05). The post-resuscitation mitral E/A and E/e' velocity ratios and left ventricular ejection fraction were significantly better in the ivabradine than placebo group (P < 0.05). The serum levels of myocardial injury biomarkers (NT-proBNP, cTnI) and the myocardial biopsy scores were significantly lower in the ivabradine than placebo group (P < 0.05). Neurological deficit scores were lower in the IVA group at PR 24 h (P < 0.05).

CONCLUSIONS: Ivabradine improved post-resuscitation myocardial dysfunction, myocardial injury, and post-resuscitation cerebral function, and also slowed the heart rate in this porcine model.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Yang M, Chen L, Hua T, et al. Beneficial Effects of Ivabradine on Post-Resuscitation Myocardial Dysfunction in a Porcine Model of Cardiac Arrest. Shock. 2020. PMID: 31274829. doi:10.1097/SHK.0000000000001403

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。